$CAHO
Caro Holdings Inc.

2023 Q2 Form 10-Q Financial Statement

#000164033423001613 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $50.00K $10.57K
YoY Change 373.04% -44.89%
% of Gross Profit
Research & Development $63.65K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $112.2K $10.57K
YoY Change 961.1% -44.88%
Operating Profit -$112.2K -$10.57K
YoY Change 961.1%
Interest Expense $38.69K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$34.07K $0.00
YoY Change
Pretax Income -$146.2K -$10.57K
YoY Change 1283.6% -44.89%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$146.2K -$10.57K
YoY Change 1283.33% -44.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$264.30
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding 60.00M shares

Balance Sheet

Concept 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents $959.00 $0.00
Short-Term Investments
Other Short-Term Assets $6.510K
YoY Change 160.4%
Inventory
Prepaid Expenses $6.505K
Receivables
Other Receivables
Total Short-Term Assets $14.58K $6.505K
YoY Change 124.14% 74.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $258.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $14.58K $6.505K
Total Long-Term Assets $258.0K $0.00
Total Assets $272.6K $6.505K
YoY Change 4090.32% 74.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $18.22K
YoY Change 448.85% 19.08%
Accrued Expenses $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $380.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $548.2K $39.08K
YoY Change 1302.86% -67.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $548.2K $39.08K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $548.2K $39.08K
YoY Change 1302.86% -67.21%
SHAREHOLDERS EQUITY
Retained Earnings -$710.2K -$218.0K
YoY Change 225.76% 31.72%
Common Stock $600.00 $400.00
YoY Change 50.0% 419.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$275.7K -$32.58K
YoY Change
Total Liabilities & Shareholders Equity $272.6K $6.505K
YoY Change 4090.32% 74.87%

Cashflow Statement

Concept 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$146.2K -$10.57K
YoY Change 1283.33% -44.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$43.74K $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$10.00K
YoY Change
Cash From Investing Activities -$7.305K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $53.90K $500.00
YoY Change 10680.0%
NET CHANGE
Cash From Operating Activities -$43.74K $0.00
Cash From Investing Activities -$7.305K $0.00
Cash From Financing Activities $53.90K $500.00
Net Change In Cash -$1.320K $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$43.74K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272580 usd
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
S3 8LT
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
266292 usd
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001678105
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60000000 shares
CY2022Q2 caro Foreign Currency Exchange Rate Translation Spot Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationSpotGbpUsdExchangeRate
0 pure
CY2022Q2 caro Foreign Currency Exchange Rate Translation Average Gbp Usd Exchange Rate
ForeignCurrencyExchangeRateTranslationAverageGbpUsdExchangeRate
0 pure
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
333-212268
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
CARO HOLDINGS INC.
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
7 Castle Street
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Sheffield
CY2023Q2 dei Entity Address Country
EntityAddressCountry
GB
CY2023Q2 dei City Area Code
CityAreaCode
786
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
755-3210
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23135000 shares
CY2023Q2 us-gaap Assets Current
AssetsCurrent
14580 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8292 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
258000 usd
CY2023Q2 us-gaap Assets
Assets
272580 usd
CY2023Q1 us-gaap Assets
Assets
266292 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
101732 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40476 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
10645 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
5290 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
56961 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
53622 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
28900 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
25000 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
350000 usd
CY2023Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
266666 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
548238 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
391054 usd
CY2023Q2 us-gaap Liabilities
Liabilities
548238 usd
CY2023Q1 us-gaap Liabilities
Liabilities
391054 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60000000 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
600 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
600 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
442828 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
442828 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-710156 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563910 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8930 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4280 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-275658 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-124762 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3342 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
37680 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
10572 usd
CY2023Q2 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
7504 usd
CY2022Q2 caro Management Consulting Fees Expense
ManagementConsultingFeesExpense
0 usd
CY2023Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
63654 usd
CY2022Q2 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
0 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
10572 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
38689 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
180 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4443 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-34066 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-146246 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10572 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10572 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4650 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-150896 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10572 usd
CY2023Q2 caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2022Q2 caro Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.00
CY2023Q2 caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
60000000 shares
CY2022Q2 caro Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
40000000 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-124762 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4650 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-275658 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-22003 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10572 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-32575 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-146246 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10572 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
33333 usd
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
180 usd
CY2022Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
0 usd
CY2023Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
97 usd
CY2022Q2 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6505 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
64097 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
17077 usd
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5355 usd
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43739 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2023Q2 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
7305 usd
CY2022Q2 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7305 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3900 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
CY2023Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000 usd
CY2022Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
500 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
53900 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
500 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4176 usd
CY2022Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1320 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
500 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2279 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1429 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
959 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1929 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q2 caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
4684 usd
CY2022Q2 caro Operating Expenses Paid By Related Parties
OperatingExpensesPaidByRelatedParties
20865 usd
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

Files In Submission

Name View Source Status
0001640334-23-001613-index-headers.html Edgar Link pending
0001640334-23-001613-index.html Edgar Link pending
0001640334-23-001613.txt Edgar Link pending
0001640334-23-001613-xbrl.zip Edgar Link pending
caro-20230630.xsd Edgar Link pending
caro_10q.htm Edgar Link pending
caro_10qimg2.jpg Edgar Link pending
caro_10qimg3.jpg Edgar Link pending
caro_ex311.htm Edgar Link pending
caro_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
caro-20230630_cal.xml Edgar Link unprocessable
caro-20230630_pre.xml Edgar Link unprocessable
caro-20230630_def.xml Edgar Link unprocessable
caro-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
caro_10q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending